Interaction of FANCD2 and NBS1 in the DNA damage response

Nature Cell Biology

Volumn 4, Issue 12, 2002, Pages 913-920

  Nakanishi, Koji ^a   Taniguchi, Toshiyasu ^a   Ranganathan, Velvizhi ^b   New, Helen V ^c   Moreau, Lisa A ^a   Stotsky, Maria ^a   Mathew, Christopher G ^d   Kastan, Michael B ^e   Weaver, David T ^b   D'Andrea, Alan D ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CELL PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; ISOPROTEIN; MITOMYCIN C; NIBRIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CELL ACTIVITY; CELL CYCLE S PHASE; CELL LINE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DNA CROSS LINKING; DNA DAMAGE; DRUG SENSITIVITY; FANCONI ANEMIA; HUMAN; HUMAN CELL; IONIZING RADIATION; NIJMEGEN BREAKAGE SYNDROME; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RADIOSENSITIVITY; WILD TYPE;

ANTIBIOTICS, ANTINEOPLASTIC; CELL CYCLE PROTEINS; CELL LINE, TRANSFORMED; CHROMOSOME BREAKAGE; CROSS-LINKING REAGENTS; DNA DAMAGE; DNA REPAIR; DRUG RESISTANCE; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; HUMANS; MITOMYCIN; NUCLEAR PROTEINS; S PHASE; ULTRAVIOLET RAYS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 4544280871     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb879     Document Type: Article

References (38)

1. Khanna, K. K. et al. Cellular responses to DNA Damage and the Human Chromosome Instability Syndromes (Humana, San Diego 1998).
2. Joenje, H. & Patel, K. J. The emerging genetic and molecular basis of fanconi anaemia. Nature Rev. Genet. 2, 446-459 (2001).
3. Weemaes, C. M. et al. A new chromosomal instability disorder: the Nijmegen breakage syndrome. Acta Paediatr. Scand. 70, 557-564 (1981).
4. Weemaes C. M., Smeets, D. F., Horstink, M. Haraldsson, A. & Bakkeren J. A. Variants of Nijmegen breakage syndrome and ataxia telangiectasia. Immunodeficiency 4, 109-111 (1993).
5. Stewart, G. S. et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99, 577-587 (1999).
6. Taniguchi, T. et al. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109, 459-472 (2002).
7. Grompe, M. & D'Andrea, A. Fanconi anemia and DNA repair. Hum. Mol. Genet. 10, 2253-2259 (2001).
8. Alter, B. P. Fanconi's anemia and malignancies. Am. J. Hematol. 53, 99-110 (1996).
9. Resnick, I. B. et al. Nijmegen breakage syndrome: Clinical characteristics and mutation analysis in eight unrelated Russian families. J. Pediatr. 140, 355-361 (2002).
10. Petrini, J. H. The Mre11 complex and ATM: collaborating to navigate S phase. Curr. Opin. Cell Biol. 12, 293-296 (2000).
11. Shiloh, Y. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu. Rev. Genet. 31, 635-662 (1997).
12. Bressan, D. A., Baxter, B. K. & Petrini, J. H. The Mre11-Rad50-Xrs2 protein complex facilitates homologous recombination-based double-strand break repair in Saccharomyces cerevisiae. Mol. Cell Biol. 19, 7681-7687 (1999).
13. Wu, X. et al. Independence of R/M/N focus formation and the presence of intact BRCA1. Science 289, 11 (2000).
14. Zhong, Q. et al. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 285, 747-750 (1999).
15. Lim, D. S. et al. ATM phosphorylates p95/NBS1 in an S-phase checkpoint pathway. Nature 404, 613-617 (2000).
16. Zhao, S. et al. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature 405, 473-477 (2000).
17. Wu, X et al. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature 405, 477-482 (2000).
18. Gatei, M. et al. ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nature Genet. 25, 115-119 (2000).
19. Garcia-Higuera, I. et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7, 249-262 (2001).
20. Moynahan, M. E., Chiu, J. W., Koller, B. H. & Jasin, M. Brca1 controls homology-directed DNA repair. Mol. Cell 4, 511-518 (1999).
21. Taniguchi, T. et al. S phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100, 2414-2420 (2002).
22. Maser, R. S., Zinkel, R. & Petrini, J. H. An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele. Nature Genet. 27, 417-421 (2001).
23. Auerbach, A. D. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp. Hematol, 21, 731-733 (1993).
24. Ranganathan, V. et al. Rescue of a telomere length defect of Nijmegen breakage syndrome cells requires NBS and telomerase catalytic subunit. Curr. Biol. 11, 962-966 (2001).
25. Desai-Mehta, A., Cerosaletti, K. M. & Concannon, P. Distinct functional domains of nibrin mediate Mre11 binding, focus formation, and nuclear localization. Mol. Cell. Biol. 21, 2184-2191 (2001).
26. Maser, R. S., Monsen, K. J., Nelms, B. E. & Petrini, J. H. J. hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double strand breaks. Mol. Cell. Biol. 17, 6087-6096 (1997).
27. Dolganov, G. M. et al. Human Rad50 is physically associated with Mre11: identification of a conserved multiprotein complex implicated in recombinational DNA repair. Mol. Cell. Biol. 16, 4832-4841 (1996).
28. Carney, J. P. et al. The hMre11/hRad50 protein complex and nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93, 477-486 (1998).
29. Abraham, R. T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15, 2177-2196 (2001).
30. Howlett, N. G. et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297, 606-609 (2002).
31. Paull, T. T. & Gellert, M. Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex. Genes Dev. 13, 1276-1288 (1999).
32. Buscemi, G. et al. Chk2 activation dependence on Nbs1 after DNA damage. Mol. Cell. Biol. 21, 5214-5222 (2001).
33. Grenon, M., Gilbert, C. & Lowndes, N. F. Checkpoint activation in response to double-strand breaks requires the Mre11/Rad50/Xrs2 complex. Nature Cell Biol. 3, 844-847 (2001).
34. Kupfer, G. et al. The Fanconi anemia protein, FAC, binds to the cyclin-dependent kinase, cdc2. Blood 90, 1047-1054 (1997).
35. Garcia-Higuera, I., Kuang, Y., Naf, D., Wasik, J. & D'Andrea, A. D. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol. Cell Biol. 19, 4866-4873 (1999).
36. Naf, D., Kupfer, G. M., Suliman, A., Lambert, K. & D'Andrea, A. D. Functional activity of the Fanconi anemia protein, FAA, requires FAC binding and nuclear localization. Mol. Cell. Biol. 18, 5952-5960 (1998).
37. 2-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 21, 3445-3450 (2001).
38. Yang, Y. et al. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood 98, 3435-3440 (2001).